共 9 条
[1]
Easterling DE,Zakszewski T,Moter MD,et al.Plasma pharmacokinetics of topiramate, a new anticonvulsant in humans. Epilepsia . 1988
[2]
Rosenfeld WE,Liao S,Kramer LD,et al.Comparison of the steady-state pharmacokinetics of topiramate and valproate in patients with epilepsy during monotherapy and concommitant therapy. Epilepsia . 1997
[3]
Brodie MJ,Biton V,Montouis GD,et al.Topiramate therapy in patients with generalized tonic-clonic seizures with or without focal onset : Long-term outcome. Epilepsia . 1998
[4]
Ritter FJ,Glauser TA,Sachdeno RC,et al.Long-term experince with topiramate in Lennox-Gastaut syndrome. Epilepsia . 1998
[5]
Glauser TA,Elterman R,Wyllic E,et al.Open-label topiramate in pediatric partial epilepsy. Epilepsia . 1997
[6]
Sachdeo RC,Sachdeo SK,Walker SA,et al.Steadystate pharmacokinetics of topiramate and carbamazepine in papients with epilepsy during monotherapy and concommitant therapy. Epilepsia . 1996
[7]
Shorvon SD.Safety of topiramate: adverse events and relationships to dosing. Epilepsia . 1996
[8]
Reife RA,Lim P,Pledger G.Topiramate: side-effect profile in double-blind studies. Epilepsia . 1995
[9]
Faught E,Wilder BJ,Ramsay RE,et al.Topiramate placebocontrolled dose-renging trial in refractory partial epilepsy using 200 -, 400 -, and 1000 - mg daily dosage. Neurology . 1996